Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression. | Histopathology | 2022 | 33948980 | PubTator, text mining | PubMed |
| Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient. | Ann Hematol | 2022 | 33438048 | PubTator, text mining | PubMed |
| The Role of Regulatory T and B Cells in the Etiopathogenesis of Idiopathic Granulomatous Mastitis. | Immunol Invest | 2022 | 33034215 | PubTator, text mining | PubMed |
| COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiency. | Clin Immunol Commun | 2021 | 38620775 | PubTator, text mining | PubMed |
| DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy. | Oncoimmunology | 2021 | 38283033 | PubTator, text mining | PubMed |
| Biological and molecular studies on specific immune cells treated with checkpoint inhibitors for the thera-personal approach of breast cancer patients (ex-vivo study). | Oncol Res | 2021 | 37305162 | PubTator, text mining | PubMed |
| Effects of Overexpression of the Egyptian Fruit Bat Innate Immune Genes on Filovirus Infections in the Host Cells. | Front Virol | 2021 | 36237518 | PubTator, text mining | PubMed |
| Whole body-diffusion weighted imaging for the assessment of treatment response in hairy cell leukaemia: A positive first step. | EJHaem | 2021 | 35845288 | PubTator, text mining | PubMed |
| Mutation profiles of diffuse large B-cell lymphoma transformation of splenic B-cell lymphoma/leukemia, unclassifiable on whole-exome sequencing. | EJHaem | 2021 | 35845190 | PubTator, text mining | PubMed |
| Correlations between Specific and Nonspecific Vaginal Immunity in Women with Breast Cancer in Kazakhstan. | Med J Islam Repub Iran | 2021 | 35685201 | PubTator, text mining | PubMed |
| Single-nucleotide polymorphisms in 3'-untranslated region inducible costimulator gene and the important roles of miRNA in alopecia areata. | Skin Health Dis | 2021 | 35664973 | PubTator, text mining | PubMed |
| Anticancer potential of nitric oxide (NO) in neuroblastoma treatment. | RSC Adv | 2021 | 35423416 | PubTator, text mining | PubMed |
| Exploration of Potential Integrated Models of N6-Methyladenosine Immunity in Systemic Lupus Erythematosus by Bioinformatic Analyses. | Front Immunol | 2021 | 35197962 | PubTator, text mining | PubMed |
| Interpreting Functional Impact of Genetic Variations by Network QTL for Genotype-Phenotype Association Study. | Front Cell Dev Biol | 2021 | 35155440 | PubTator, text mining | PubMed |
| An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases. | Front Pharmacol | 2021 | 35153741 | PubTator, text mining | PubMed |
| Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy. | Front Immunol | 2021 | 35126374 | PubTator, text mining | PubMed |
| A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma. | Transl Cancer Res | 2021 | 35116551 | PubTator, text mining | PubMed |
| The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19. | Front Immunol | 2021 | 35095917 | PubTator, text mining | PubMed |
| Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration. | Front Immunol | 2021 | 35095855 | PubTator, text mining | PubMed |
| HPV-16 E7-Specific Cellular Immune Response in Women With Cervical Intraepithelial Lesion Contributes to Viral Clearance: A Cross-Sectional and Longitudinal Clinical Study. | Front Immunol | 2021 | 35095843 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=59